Oxford Gene Technology Developed Novel Biomarker for Improved Lupus Diagnosis

The British company Oxford Gene Technology (OGT) announced the development of a novel biomarker panel to improve diagnosis of lupus.

The biomarker panel has been rigorously tested among samples from North American, European and Afro-Caribbean lupus patients and shown to be Our more sensitive and specific than existing laboratory tests.